View Item 

Show simple item record

Azithromycin‐Warfarin Interaction: Are We Fishing with a Red Herring?

dc.contributor.authorEschenauer, Gregory A.en_US
dc.contributor.authorCollins, Curtis D.en_US
dc.contributor.authorRegal, Randolph E.en_US
dc.date.accessioned2012-03-16T15:54:24Z
dc.date.available2012-03-16T15:54:24Z
dc.date.issued2005-04en_US
dc.identifier.citationEschenauer, Gregory; Collins, Curtis D.; Regal, Randolph E. (2005). "Azithromycin‐Warfarin Interaction: Are We Fishing with a Red Herring?." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25(4). <http://hdl.handle.net/2027.42/90099>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90099
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.subject.otherInfectionen_US
dc.subject.otherAzithromycinen_US
dc.subject.otherWarfarinen_US
dc.subject.otherDrug Interactionen_US
dc.subject.otherIsoenzymeen_US
dc.titleAzithromycin‐Warfarin Interaction: Are We Fishing with a Red Herring?en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacy Services, University of Michigan Health System, Ann Arbor, Michigan.en_US
dc.identifier.pmid15977924en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90099/1/phco.25.4.630.61028.pdf
dc.identifier.doi10.1592/phco.25.4.630.61028en_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceLiao S, Palmer M, Fowler C, et al. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. J Clin Pharmacol 1996; 36: 1072 – 7.en_US
dc.identifier.citedreferenceEllis RJ, Mayo MS, Bodensteiner DM. Ciprofloxacin‐warfarin coagulopathy: a case series. Am J Hematol 2000; 63: 28 – 31.en_US
dc.identifier.citedreferenceShrader SP, Fermo JD, Dzikowski AL. Azithromycin and warfarin interaction. Pharmacotherapy 2004; 24 ( 7 ): 945 – 9.en_US
dc.identifier.citedreferenceMorgan ET. Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 1997; 29 ( 4 ): 1129 – 88.en_US
dc.identifier.citedreferenceRenton KW. Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol Ther 2001; 92 ( 2–3 ): 147 – 63.en_US
dc.identifier.citedreferenceRenton KW. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab 2004; 5 ( 3 ): 235 – 43.en_US
dc.identifier.citedreferenceSonne J, Dossing M, Loft S, Andreasen PB. Antipyrine clearance in pneumonia. Clin Pharmacol Ther 1985; 37: 701 – 4.en_US
dc.identifier.citedreferenceNicholson TE, Renton KW. Role of cytokines in the lipopolysaccharide‐evoked depression of cytochrome P450 in the brain and liver. Biochem Pharmacol 2001; 62 ( 12 ): 1709 – 17.en_US
dc.identifier.citedreferenceShearer MJ, Bechtold H, Andrassy K, et al. Mechanism of cephalosporin‐induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism and vitamin K status. J Clin Pharmacol 1988; 28: 88 – 95.en_US
dc.identifier.citedreferenceGheno G, Cinetto L. Levofloxacin‐warfarin interaction [letter]. Eur J Clin Pharmacol 2001; 57: 427.en_US
dc.identifier.citedreferenceJones CB, Fugate SE. Levofloxacin and warfarin interaction. Ann Pharmacother 2002; 36 ( 10 ): 1554 – 7.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
phco.25.4.630.61028.pdf
Size:
117.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.